Monday, February 13th, 2012
5 Percent Increase Leads to Second Consecutive Yearly Gain
For Immediate Release: 02/09/2012
ARLINGTON HEIGHTS, Ill. – The plastic surgery market continues to show significant growth – two years in a row. According to statistics released today by the American Society of Plastic Surgeons (ASPS), 13.8 million cosmetic plastic surgery procedures (both surgical and minimally-invasive) were performed in the United States in 2011, up 5 percent since 2010. In addition, 5.5 million reconstructive plastic surgery procedures were performed last year, up 5 percent.
“While the rate of economic recovery in the U.S. is still uncertain, 2011 proved to be a good year for plastic surgery,” said ASPS President Malcolm Z. Roth, MD. “Consumer confidence was up, auto sales rose 10 percent, so it is not surprising that we would also see increased demand for plastic surgery procedures.”
Cosmetic surgical procedures increased 2 percent, with nearly 1.6 million procedures in 2011. The top five surgical procedures were:
• Breast augmentation (307,000 procedures, up 4 percent)
• Nose reshaping (244,000 procedures, down 3 percent)
• Liposuction (205,000 procedures, up 1 percent)
• Eyelid surgery (196,000 procedures, down 6 percent)
• Facelift (119,000 procedures, up 5 percent)
Facelifts are among the top five cosmetic surgical procedures for the first time since 2004, replacing tummy tucks. Interestingly, a procedure popular with men, chin augmentation, nearly doubled in 2011, with 21,000 procedures performed, up 71 percent. Lip augmentation also rose significantly – up 49 percent, with more than 25,000 procedures performed.
“We are seeing notable increases in surgical procedures, such as facelifts, that reflect the demands of an aging boomer population,” said Dr. Roth. “However, the overall growth in cosmetic procedures is being primarily driven by a substantial rise in minimally-invasive procedures.”
Cosmetic minimally-invasive procedures increased 6 percent, with nearly 12.2 million procedures in 2011. The top five minimally-invasive procedures were:
• Botulinum toxin type A (5.7 million procedures, up 5 percent)
• Soft tissue fillers (1.9 million procedures, up 7 percent)
• Chemical peel (1.1 million procedures, down 3 percent)
• Laser hair removal (1.1 million procedures, up 15 percent)
• Microdermabrasion (900,000 procedures, up 9 percent)
Soft tissue fillers like hyaluronic acid (Restylane®, Juvederm Ultra®, etc.), calcium hydroxylapatite (Radiesse®), and fat injections experienced some of the largest growth in the minimally-invasive market during 2011. More than 1.3 million hylauronic acid procedures were performed in 2011, up 9 percent; 286,000 calcium hydroxylapatite procedures, up 36 percent; and 68,000 fat injections, up 19 percent.
Reconstructive plastic surgery, which improves function and appearance to abnormal structures, increased 5 percent in 2011. The top five reconstructive procedures were:
• Tumor removal (4.2 million, up 3 percent)
• Laceration repair (303,000, down 15 percent)
• Maxillofacial surgery (195,000, up 125 percent)
• Scar revision (175,000, up 9 percent)
• Hand surgery (120,000, up 13 percent)
Breast reconstruction rates continue to rise, with more than 96,000 procedures performed last year, up 3 percent since 2010.
“While insurance coverage for breast reconstruction is mandated by law, continued strides to provide coverage for other reconstructive procedures has contributed, in part, to the sizable gain that we are seeing with these procedures,” said Dr. Roth. “Reconstructive surgery is a critical pillar of the specialty, and it is encouraging to see that increasing numbers of patients entrust board-certified plastic surgeons to reconstruct their bodies after disease or trauma.”
ASPS members can report procedural information through the first online national database for plastic surgery procedures, Tracking Operations and Outcome for Plastic Surgeons (TOPS). This data, combined with the annual survey sent to American Board of Medical Specialties certified physicians most likely to perform these procedures, results in the most comprehensive census on plastic surgery.
To view the 2011 National Clearinghouse of Plastic Surgery Statistics report, click HERE. Visitors can also find information about procedures and referrals to ASPS Member Surgeons.
For more information on any of these plastic or reconstructive surgery procedures, contact Dr. Kapp at his West Palm Beach office at (561) 833-4022.
About ASPS
The American Society of Plastic Surgeons (ASPS) is the world’s largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. For more information, please visit www.plasticsurgery.org.
Tags: BOTOX®, Breast Augmentation, breast reconstruction, chin augmentation, eyelid surgery, Facelift, JUVÉDERM®, Liposuction, nose surgery, Plastic Surgery, plastic surgery for men, Radiesse, Reconstructive Surgery, Restylane®, Tummy Tuck
Posted in Breast Procedures, Cosmetic Surgery, Dr. Kapp's Blog, Plastic Surgery Procedures, Reconstructive Surgery, Skin Procedures No Comments »
Thursday, February 9th, 2012
Medicis Aesthetics, the manufacturer of Restylane, recently announced that Restylane has received FDA approval to be used for lip augmentation. Although Restylane has been used extensively for lip augmentation, doing so was considered an off-label indication. Restylane, a hyaluronic acid dermal filler, was first approved in 2005 for mid to deep dermal injection for the correction of moderate to severe facial wrinkles and folds.
An FDA advisory panel had previously voted 6-0 with 1 abstention that the benefits of using Restylane as an injection for lip augmentation outweighed its risks, and that the filler was safe and effective for this indication. The panel reviewed the results of a study of 135 patients who received Restylane and 45 patients with no treatment. Almost all patients (99%) experienced adverse events, which included bruising, redness, swelling, pain, tenderness, itching, and skin exfoliation. Of those who were treated, 15% experienced adverse events (typically swelling and tenderness) that lasted more than 15 days.
Restylane and Juvederm are the most commonly utilized hyaluronic acid fillers in the United States. To learn more about treatments with Restylane and Juvederm, contact Dr. Kapp’s West Palm Beach office at (561) 833-4022.
Tags: FDA approval, Fillers, Injectables, JUVÉDERM®, lip augmentation, Restylane®
Posted in Dr. Kapp's Blog, Plastic Surgery Procedures, Plastic Surgery Safety, Skin Procedures No Comments »
Wednesday, February 1st, 2012
Dear Dr. Kapp,
           I just wanted to thank you for the kindness you have shown to both my mother and me. Your gentle manner and the special attention you personally gave me are very much appreciated during this extremely difficult time.
                                                           Most Sincerely,
                                                           Suzanne

Tags: Dr. Kapp, patient testomonials, thank you
Posted in Our Patient Testimonials No Comments »